FDA Approves RHA Filler for Midface Contour Deficiencies
The approval covers cheek augmentation and age-related midface contour deficiencies, supported by phase III clinical trial data.
The approval covers cheek augmentation and age-related midface contour deficiencies, supported by phase III clinical trial data.
The device uses 2.45-GHz energy and three handpieces designed to target subcutaneous tissue while maintaining surface cooling, according to the company.